PIPERACETAZINE

SynDRA canonical compound SYN0011767 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Mechanism of action	dopamine receptor antagonist
Indication	schizophrenia
Disease area	neurology/psychiatry

All known targets

psymod
quide
Piperacetazina
NSC-760067
PC-1421
Quide
Psymod
Piperacetazinum
1-[10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]phenothiazin-2-yl]ethanone
SC 9794
NSC 760067
KL6248WNW4
10-(3-(4-(2-Hydroxyethyl)piperidino)propyl)phenothiazin-2-yl methyl ketone
Ethanone, 1-(10-(3-(4-(2-hydroxyethyl)-1-piperidinyl)propyl)-10H-phenothiazin-2-yl)-
NCGC00016642-01
CAS-3819-00-9
Ketone, 10-(3-(4-(2-hydroxyethyl)piperidino)propyl)phenothiazin-2-yl methyl
1-(10-(3-(4-(2-Hydroxyethyl)-1-piperidinyl)propyl)-10H-phenothiazin-2-yl)ethanone
Piperacetazina [INN-Spanish]
Piperazetazina
Piperazetazina [DCIT]
10-[3-[4-(2-hydroxyethyl)piperidino]propyl]phenothiazin-2-yl methyl ketone
Ethanone, 1-[10-[3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl]-10H-phenothiazin-2-yl]-
Piperacetazinum [INN-Latin]
EINECS 223-312-0
UNII-KL6248WNW4
Piperacetazine [USAN:USP:INN]
1-(10-{3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl}-10H-phenothiazin-2-yl)ethanone
Quide (TN)
Prestwick0_001048
Prestwick1_001048
Prestwick2_001048
Prestwick3_001048
2-Acetyl-10-(3-(4-(beta-hydroxyethyl)piperidino)propyl)phenothiazine
PIPERACETAZINE [MI]
CHEMBL1584
Piperacetazine (USAN/INN)